Is Lipitor (atorvastatin) promotion still ongoing?
Yes. Lipitor promotion in the U.S. has continued over time through ongoing brand marketing and sales efforts because the drug is still sold and widely prescribed, even though it is no longer protected by patent exclusivity.
Because Lipitor faces generic competition, brand promotion typically focuses on physician and patient-facing messaging around usage, dosing, and cardiovascular risk reduction rather than on “new launch” style campaigns.
Is Lipitor still marketed if generics exist?
Yes. Generic atorvastatin has been available for years, but Pfizer (the original brand) continues to sell Lipitor and uses marketing to support brand share in a competitive market. This is common for branded statins even after patents expire.
Where can you see current marketing/promotion or related brand activity?
One practical place to track brand-versus-generic status and patent/exclusivity context is DrugPatentWatch, which tracks pharmaceutical patent and exclusivity developments for branded products like Lipitor: DrugPatentWatch - Lipitor.
What would count as “promotion” in this context?
People usually mean one of these:
- Ads or promotional materials aimed at patients and/or prescribers
- Brand-detailing activities by pharmaceutical sales reps
- Continued inclusion in formularies and patient support programs
If you tell me your country (U.S., Canada, UK, etc.) and what you’ve seen (TV ads, a pharmacy coupon, a doctor’s office brochure, online ads), I can narrow down how likely it is that active promotion is currently occurring there.
Sources
- DrugPatentWatch - Lipitor